1244054

Voiant LLC — FEI 3011114764

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 9, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Los Angeles, CA (United States)

Additional Details

Sponsor, Contract Research Organization